Symbol="ABEO"
AssetType="Common Stock"
Name="Abeona Therapeutics Inc"
Description="Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for rare, life-threatening genetic diseases. The company is headquartered in New York, New York."
CIK="318306"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1330 AVENUE OF THE AMERICAS, 33RD FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="88006000"
EBITDA="-39929000"
PERatio="None"
PEGRatio="0"
BookValue="1.045"
DividendPerShare="0"
DividendYield="0"
EPS="-2.27"
RevenuePerShareTTM="0.1"
ProfitMargin="0"
OperatingMarginTTM="-40.14"
ReturnOnAssetsTTM="-0.494"
ReturnOnEquityTTM="-1.067"
RevenueTTM="1068000"
GrossProfitTTM="-28001000"
DilutedEPSTTM="-2.27"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.977"
AnalystTargetPrice="21.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="10.71"
PriceToBookRatio="3.31"
EVToRevenue="9.47"
EVToEBITDA="-0.515"
Beta="1.364"
num_52WeekHigh="5.8"
num_52WeekLow="2.19"
num_50DayMovingAverage="3.76"
num_200DayMovingAverage="3.304"
SharesOutstanding="22062600"
DividendDate="None"
ExDividendDate="None"
symbol="ABEO"
open="4.00"
high="4.06"
low="3.85"
price="3.88"
volume="154516.00"
latest_trading_day="2023-07-14"
previous_close="3.99"
change="-0.11"
change_percent="-2.7569%"
aroon_positive_momentum_days="88"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="88"
Volume_recent_avg="168054"
Change_recent_avg="0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="88"
Aroon_momentum_negative="12"
image_negative_thumbnail_id_1="513"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_negative_thumbnail_id_2="1125"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0158.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="527"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0072.jpeg"
image_positive_thumbnail_id_1="1004"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0166.jpeg"
image_positive_thumbnail_id_2="615"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0093.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
